MSR20 Challenges in the Development of Economic Evaluations for Psychedelics in Treatment of Depression
No abstract is available for this record.
Psilocybin-Research.comSearchable psilocybin and psilocin bibliometric database.Bibliographic context
- Journal
- Value in Health
- Date
- 2022-06-24
- Source
- OpenAlex
- PubMed
- Unavailable
Topics and keywords
Citation graph
0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.
Indexed papers citing this DOI
Related papers
Hallucinogens for Mood and Anxiety Disorders: A Critical Review of Psychedelic-Assisted TherapiesThinkIR: The University of Louisville's Institutional Repository (University of Louisville) · 2026-03-15THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERSInternational Journal of Innovative Technologies in Social Science · 2026-01-22Self-reported improvement in depression, anxiety, and substance use in Spanish-speakers after a memorable psychedelic experiencePsychedelics · 2025-11-19Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibilityFrontiers in Neuroscience · 2026-03-22Psychedelics in psychiatric treatment: a literature reviewQuality in Sport · 2026-01-25Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility studyAddiction · 2025-09-19Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical ImplicationsFOCUS The Journal of Lifelong Learning in Psychiatry · 2026-03-31Editorial: Psychedelic substances and neurological diseases: from basics to clinical applicationFrontiers in Pharmacology · 2026-03-15